Records containing: Stage III Breast Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-12-20A Phase II Study of Neoadjuvant Chemotherapy With and Without Trastuzumab in Patients With Breast Cancer
-
CLINICAL_TRIALS study record update · 2023-12-14Can Aerobic and Strength Training Exercise Initiated During and Continued After Radiation Therapy for Breast Cancer Improve Fitness and Arm Health 1 Year Later?
-
CLINICAL_TRIALS study record update · 2023-08-16Ask Questions (ASQ): Implementation of a Communication Intervention to Improve Patient-Oncologist Communication in the Outpatient Medical Oncology Setting
-
CLINICAL_TRIALS study record update · 2022-10-19A Phase 1B Dose Escalation Trial of Human Anti 4 1BB Agonistic Antibody Utomilumab (PF 05082566) in Combination With Ado Trastuzumab Emtansine or Trastuzumab in Patients With HER2 Postive Advanced Breast Cancer
-
CLINICAL_TRIALS study record update · 2022-10-05A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-09-26A Phase Ib Trial Evaluating the Safety of Copanlisib, Letrozole, and Palbociclib in Metastatic Breast Cancer and Phase II Trial Comparing the Molecular Effects of Neoadjuvant Copanlisib in Combination With Palbociclib and Letrozole, vs. Copanlisib With Letrozole, vs. Palbociclib With Letrozole for Patients With Hormone Receptor Positive, HER2 Normal Breast Cancer
-
CLINICAL_TRIALS study record update · 2021-11-02Living Well After Breast Surgery
-
CLINICAL_TRIALS study record update · 2021-08-11BRE 17107: A Phase Ib/II Trial of Atezolizumab (an Anti-PD-L1 Monoclonal Antibody) With Cobimetinib (a MEK1/2 Inhibitor) or Idasanutlin (an MDM2 Antagonist) in Metastatic ER+ Breast Cancer
-
CLINICAL_TRIALS study record update · 2021-06-11An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
-
CLINICAL_TRIALS study record update · 2021-05-11The Impact of HER2 Heterogeneity on the Treatment of Early-stage HER2-positive Breast Cancer: a Phase II Study of T-DM1 in Combination With Pertuzumab in the Preoperative Setting
-
CLINICAL_TRIALS study record update · 2021-04-08Couple-Focused ACT Intervention for Couples Coping With Cancer: A Pilot Study
-
CLINICAL_TRIALS study record update · 2020-07-13Phase II Study of Pembrolizumab and Capecitabine for Advanced Triple Negative and Hormone-Refractory Breast Cancer
-
CLINICAL_TRIALS study record update · 2019-10-24Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Survivors
-
CLINICAL_TRIALS study record update · 2019-08-09A Trail of Neoadjuvant Endostar in Combination With Docetaxel, Epirubicin and Cyclophosphamide in Patients With Stage III Breast Cancer (TENDENCY)
-
CLINICAL_TRIALS study record update · 2019-06-26Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin
-
CLINICAL_TRIALS study record update · 2019-01-15Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-11-23Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors. A Phase II Study to Identify Molecular Predictors for Hormone Responsiveness and/or Resistance.
-
CLINICAL_TRIALS study record update · 2016-05-19Phase II Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer
-
CLINICAL_TRIALS study record update · 2015-11-11A Phase II Study of Preoperative Capecitabine in Women With Operable Breast Cancer
-
CLINICAL_TRIALS study record update · 2014-09-08A Pilot Study Evaluating Surrogates of Response to Short Term Oral Suberoylanilide Hydroxamic Acid (SAHA) in Women With Newly Diagnosed Breast Cancer
-
CLINICAL_TRIALS study record update · 2014-04-15Phase II Neoadjuvant Trial of Capecitabine, Cyclophosphamide and Epirubicin for Patients With Axillary Lymph Node Positive Stage II-III Operable Breast Cancer
-
CLINICAL_TRIALS study record update · 2013-05-17A Multi-Institutional Phase II Study Evaluating Surrogate Biomarkers of Response to Short Term Oral Vorinostat and Tamoxifen in Women With Newly Diagnosed Breast Cancer